Bryan A. Glezerson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bryan A. Glezerson has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Christopher D. Sibley
The University of Calgary, Calgary, Alberta, Canada
2 shared publicationsHarvey R. Rabin
The University of Calgary, Calgary, Alberta, Canada
2 shared publications- Matthew L. Workentine
Faculty of Veterinary Medicine, University of Calgary, Calgary, Canada
2 shared publications Swathi Purighalla
The University of Calgary, Calgary, Alberta, Canada
2 shared publicationsAlana. M. Flexman
Department of Anesthesiology and Perioperative Care, Vancouver General Hospital
1 shared publicationBronwen B. Grocott
Department of Anesthesiology, Perioperative and Pain Medicine, University of Manitoba, Winnipeg, MB, Canada
1 shared publication
Latest Publications
- 20 November 2020
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 68 (3) , 428-429
On the stated association between labour epidural analgesia and risk of autism spectrum disorder in offspring
- 20 November 2020
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 68 (3) , 428-429
On the stated association between labour epidural analgesia and risk of autism spectrum disorder in offspring
- 1 September 2020
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 34 (9) , 2349-2354
Postcardiac Surgery Acute Stroke Therapies: A Systematic Review
- 1 September 2020
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 34 (9) , 2349-2354
Postcardiac Surgery Acute Stroke Therapies: A Systematic Review
- 29 May 2020
- Published by Wiley in Anaesthesia
- Vol. 75 (12) , 1566-1569
Thinking outside the (acrylic) box: a framework for the local use of custom‐made medical devices
- 29 May 2020
- Published by Wiley in Anaesthesia
- Vol. 75 (12) , 1566-1569
Thinking outside the (acrylic) box: a framework for the local use of custom‐made medical devices
- 27 April 2020
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 67 (10) , 1442-1443
Naloxone as an antidote for angiotensin converting enzyme inhibitor poisoning: a case report
- 27 April 2020
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 67 (10) , 1442-1443
Naloxone as an antidote for angiotensin converting enzyme inhibitor poisoning: a case report
- 1 January 2020
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 32 (1) , 1-3
The Promise and Perils of Big Data in the Clinical Neurosciences
- 1 January 2020
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 32 (1) , 1-3
The Promise and Perils of Big Data in the Clinical Neurosciences
- Open Access
- 19 November 2018
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 66 (3) , 348-349
Focus on Peer Review: An Online Peer Review Course by Nature Masterclasses
- 19 November 2018
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 66 (3) , 348-349
Open AccessFocus on Peer Review: An Online Peer Review Course by Nature Masterclasses
- 1 April 2014
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 52 (4) , 1127-1135
Twenty-Five-Year Outbreak of Pseudomonas aeruginosa Infecting Individuals with Cystic Fibrosis: Identification of the Prairie Epidemic Strain
Transmissible strains of Pseudomonas aeruginosa have been described for cystic fibrosis (CF) and may be associated with a worse prognosis. Using a comprehensive strain biobank spanning 3 decades, we sought to determine the prevalence and stability of chronic P. aeruginosa infection in an adult population. P. aeruginosa isolates from sputum samples collected at initial enrollment in our adult clinic and at the most recent clinic visit were examined by a combination of pulsed-field gel electrophoresis and multilocus sequence typing and compared against a collection of established transmissible and local non-CF bronchiectasis (nCFB) isolates. A total of 372 isolates from 107 patients, spanning 674 patient-years, including 66 patients with matched isolates from initial and final encounters, were screened. A novel clone with increased antibacterial resistance, termed the prairie epidemic strain (PES), was found in 29% (31/107 patients) of chronically infected patients referred from multiple prairie-based CF centers. This isolate was not found in those diagnosed with CF as adults or in a control population with nCFB. While 90% (60/66 patients) of patients had stable infection over a mean of 10.8 years, five patients experienced strain displacement of unique isolates, with PES occurring within 2 years of transitioning to adult care. PES has been present in our cohort since at least 1987, is unique to CF, generally establishes chronic infection during childhood, and has been found in patients at the time of transition of patients from multiple prairie-based CF clinics, suggesting broad endemicity. Studies are under way to evaluate the clinical implications of PES infection.
- 1 April 2014
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 52 (4) , 1127-1135
Twenty-Five-Year Outbreak of Pseudomonas aeruginosa Infecting Individuals with Cystic Fibrosis: Identification of the Prairie Epidemic Strain
Transmissible strains of Pseudomonas aeruginosa have been described for cystic fibrosis (CF) and may be associated with a worse prognosis. Using a comprehensive strain biobank spanning 3 decades, we sought to determine the prevalence and stability of chronic P. aeruginosa infection in an adult population. P. aeruginosa isolates from sputum samples collected at initial enrollment in our adult clinic and at the most recent clinic visit were examined by a combination of pulsed-field gel electrophoresis and multilocus sequence typing and compared against a collection of established transmissible and local non-CF bronchiectasis (nCFB) isolates. A total of 372 isolates from 107 patients, spanning 674 patient-years, including 66 patients with matched isolates from initial and final encounters, were screened. A novel clone with increased antibacterial resistance, termed the prairie epidemic strain (PES), was found in 29% (31/107 patients) of chronically infected patients referred from multiple prairie-based CF centers. This isolate was not found in those diagnosed with CF as adults or in a control population with nCFB. While 90% (60/66 patients) of patients had stable infection over a mean of 10.8 years, five patients experienced strain displacement of unique isolates, with PES occurring within 2 years of transitioning to adult care. PES has been present in our cohort since at least 1987, is unique to CF, generally establishes chronic infection during childhood, and has been found in patients at the time of transition of patients from multiple prairie-based CF clinics, suggesting broad endemicity. Studies are under way to evaluate the clinical implications of PES infection.
- Open Access
- 3 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e60225
Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
The opportunistic pathogen Pseudomonas aeruginosa chronically infects the lower airways of patients with cystic fibrosis. Throughout the course of infection this organism undergoes adaptations that contribute to its long-term persistence in the airways. While P. aeruginosa diversity has been documented, it is less clear to what extent within-patient diversity contributes to the overall population structure as most studies have been limited to the analysis of only a few isolates per patient per time point. To examine P. aeruginosa population structure in more detail we collected multiple isolates from individual sputum samples of a patient chronically colonized with P. aeruginosa . This strain collection, comprised of 169 clonal isolates and representing three pulmonary exacerbations as well as clinically stable periods, was assayed for a wide selection of phenotypes. These phenotypes included colony morphology, motility, quorum sensing, protease activity, auxotrophy, siderophore levels, antibiotic resistance, and growth profiles. Each phenotype displayed significant variation even within isolates of the same colony morphotype from the same sample. Isolates demonstrated a large degree of individuality across phenotypes, despite being part of a single clonal lineage, suggesting that the P. aeruginosa population in the cystic fibrosis airways is being significantly under-sampled.
- 3 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e60225
Open AccessPhenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
The opportunistic pathogen Pseudomonas aeruginosa chronically infects the lower airways of patients with cystic fibrosis. Throughout the course of infection this organism undergoes adaptations that contribute to its long-term persistence in the airways. While P. aeruginosa diversity has been documented, it is less clear to what extent within-patient diversity contributes to the overall population structure as most studies have been limited to the analysis of only a few isolates per patient per time point. To examine P. aeruginosa population structure in more detail we collected multiple isolates from individual sputum samples of a patient chronically colonized with P. aeruginosa . This strain collection, comprised of 169 clonal isolates and representing three pulmonary exacerbations as well as clinically stable periods, was assayed for a wide selection of phenotypes. These phenotypes included colony morphology, motility, quorum sensing, protease activity, auxotrophy, siderophore levels, antibiotic resistance, and growth profiles. Each phenotype displayed significant variation even within isolates of the same colony morphotype from the same sample. Isolates demonstrated a large degree of individuality across phenotypes, despite being part of a single clonal lineage, suggesting that the P. aeruginosa population in the cystic fibrosis airways is being significantly under-sampled.